ARCHIVES

CTCs Do Not Affect Survival, But Could Signal Metastases

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

December 26, 2003

NIH Entertainment: Wild Type Wins First, The Directors Second, In Battle of Bands

October 15, 1999

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

DCBD Board Okays Concept Of Program Announcement To Stimulate Human Monoclonal Antibody Research

June 4, 1982

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007